Terms: = Lymphoma AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Prognosis
4 results:
1. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract] [Full Text] [Related]
2. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
Tigay JH
J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
[TBL] [Abstract] [Full Text] [Related]
3. Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes.
Ohyashiki K; Ohyashiki JH; Shimamoto T; Toyama K
Leuk Lymphoma; 1996 Nov; 23(5-6):431-6. PubMed ID: 9031072
[TBL] [Abstract] [Full Text] [Related]
4. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
[TBL] [Abstract] [Full Text] [Related]
